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An important factor complicating the recovery of recom- 
binant proteins from Escherichia coli is their intracellu- 
lar location. A n  alternative to  the commonly used 
method of releasing these proteins by mechanical dis- 
ruption is to chemically permeabilize the cells. The ob- 
jective of this research was to characterize the protein 
release kinetics of a permeabilization process using 
guanidine-HCI and Triton XIOO. The protein release rate 
and  yield were  de te rmined  a s  a funct ion of t he  
guanidine and Triton concentrations. The initial release 
rate increased monotonically with increasing concentra- 
tions of Triton and guanidine whereas the release yield 
varied in a complex manner. Electron microscopy indi- 
cated that the permeabilization process involves a solu- 
bilization of t he  i n n e r  membrane  and molecular 
alteration of the outer wall. Some advantages of this 
process over mechanical disruption include avoiding ex- 
tensive fragmentation of the cells and retainment of nu- 
cleic acids inside the cell structure. 
INTRODUCTION 
The development of recombinant DNA technology has 
made it feasible to produce a wide range of valuable 
protein products in the bacterium Escherichia coli. An im- 
portant factor complicating the recovery process is reten- 
tion of the product inside the microbial cell. This has 
necessitated the use of processes capable of releasing 
protein from E .  coli. Protein release on an industrial scale 
is commonly achieved by mechanically breaking the cell in 
a high-pressure homogenizer or a ball mill. These mechani- 
cally based protein release methods have several undesir- 
able properties. One problem is that extensive fragmenta- 
tion of the cells can make the subsequent clarification 
difficult.'32 Adding to the problem of cell fragment re- 
moval is the high viscosity often imparted to the solution 
by the released nucleic acids.3 A nucleic acid removal step 
is usually necessary to accomplish one or more of the fol- 
lowing: decrease the solution viscosity, avoid potential 
interference with fractional precipitation and chromato- 
g r a p h ~ , ~  and lower the DNA concentration, in the final 
product to an acceptable level. Another undesirable prop- 
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erty is that the harsh action of mechanical disruption 
causes the release of nearly all soluble cellular protein. 
Extensive purification schemes may be required to isolate 
the product from these extraneous cellular proteins. 
Since protein release is the first recovery process, it im- 
pacts all downstream steps. Consequently, it would be ad- 
vantageous to optimize the release step with criteria that 
keep this relationship in mind. The ideal protein release 
process would give a selective and rapid release of the 
product from the cell. Undesired cell components such as 
nucleic acids and native cell proteins would be retained in 
the cell. The resulting solution could be readily clarified 
by filtration or centrifugation because the cells have not 
been fragmented. Obviously, no protein release step could 
result in a pure product, but it may be possible to develop 
a process which approximates the ideal release charac- 
teristics to a greater extent than mechanical disruption 
methods. 
One alternative to mechanical disruption is to utilize 
chemicals which interact with the cell structure in a man- 
ner which causes it to become permeable. An excellent re- 
view of a wide range of chemicals that can alter the 
permeability of many microorganisms can be found in 
Felix.5 In this article, we examine the potential of 
guanidine-HC1 and Triton XlOO to release proteins from 
E .  coli. Guanidine-HC1, a chaotropic agent, has been 
demonstrated to be capable of solubilizing protein from 
E .  coli membrane fragments.6 Triton X100, a nonionic de- 
tergent that has a high binding affinity for hydrophobic 
species, is very effective in binding to and solubilizing 
phospholipids from E. coli inner-membrane and outer-wall 
 fragment^.^ Consequently, guanidine-HC1 and Triton 
X100, by interacting with the E. coli cell structure, could 
lead to an effective permeabilization method. 
MATERIALS AND METHODS 
Cell Growth 
Escherichia coli K12, strain W3110, was maintained in 
a 50% glycerol solution at -15°C. A portion of the glyc- 
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erol stock culture was used to inoculate 1000 mL Luria 
broth (10 g/L bacto tryptone, 5 g/L bacto yeast extract, 
0.5 g/L NaCl, pH 7.0) supplemented with 5 g/L glucose. 
Following overnight growth at 37°C on a rotary shaker 
(300 rpm), the culture was used as an inoculum for a 14-L 
fermentation using 10 L defined media (Table I).  The fer- 
mentation was conducted at 37°C and the pH was main- 
tained at 7.0 by the addition of NH,OH, which also served 
as an additional nitrogen source. Cell growth was moni- 
tored by periodically withdrawing a sample and measuring 
the optical density with a Klett-Sumerson photoelectric 
colorimeter. Late in the exponential growth phase, the fer- 
mentation broth was harvested and immediately cooled 
to 4°C. 
from the pellets and both were kept for analysis. Un- 
centrifuged samples of the reaction mixture, referred to 
as “whole-broth” samples, were also taken and kept for 
analysis. 
Mechanical Disruption 
Mechanical disruption was accomplished by grinding an 
E .  coli cell suspension with 0.1-mm glass beads in  a 
Biospec Products bead beater. The bead beater was oper- 
ated for 30-s periods separated by 30-s intervals during 
which time the chamber was kept immersed in the ice 
bath. The disrupted cell suspension was centrifuged at 
13,OOOg for 30 min. 
Chemical Permeabilization Electron Microscopy 
The cooled fermentation broth was centrifuged at 4°C 
for 15 min at 6000g. The cell pellet was washed with the 
treatment buffer (0.1M Tris, pH 7.0) and centrifuged. The 
resulting cell pellet was resuspended in buffer to give a 
final cell density of approximately 50 g protein/L. Thirty 
milliliters of the dense cell suspension was placed in a 
1000-mL Erlenmeyer flask. The permeabilization process 
was initiated by adding 70 mL buffered solution contain- 
ing guanidine-HC1 and/or Triton X 100. The solutions 
were rapidly mixed and agitated at 300 rpm on a rotary 
shaker which was located in a 4°C walk-in incubator. The 
reported concentrations of Triton X 100, guanidine-HC1, 
and cells always correspond to the concentrations of the 
final reaction mixture. For each experiment, a control con- 
sisting of 30 mL dense cell suspension and 70 mL buffer 
was also run. 
Sampling Procedure 
The electron microscopy procedure consisted of several 
stages: fixation, dehydration, infiltration, embedding, sec- 
tioning/staining , and micrograph development. The proce- 
dures are similar to those described by Baic.8 The first 
stage, fixation, consisted of adding 0.4 mL 40% glu- 
taraldehyde fixative (50 mL 50% glutaraldehyde, 3.5 mL 
0.35M Na,HPO,, 9 mL d-H,O) to 5.0 mL cell suspension 
(i.e., the gu-HC1-Triton cell reaction mixture). The cells 
were fixed for 1 h at 4°C followed by 1 h at room tempera- 
ture. The glutaraldehyde fixed cells were then centrifuged 
at 13,OOOg for 15 min. The cell pellet (-0.75 mL) was re- 
suspended in 1.5 mL 50°C 2% agar noble by stirring with 
a metal rod. The mixture was then spread over a glass 
slide, aIIowed to cooI, and cut into I-mm cubes. The agar 
cubes were washed in phosphate buffer (14.2 g /L  
Na,HPO,, 7.1 g/L KH,PO,, pH 7.0) 3 times, each wash 
being 20 min. The cubes were postfixed with 1% OsO, 
fixative for 3 h at room temperature. The 1% OsO, fixa- 
tive was prepared just prior to fixation by mixing 1 part 
~~ 
One-milliliter portions of the reaction mixtures were 
withdrawn at various times for sample analysis. The sam- 
ples were centrifuged at 12,OOOg for 20 min in an Eppen- 
dorf 5415 centrifuge. The supernatants were then separated 
4% OsO,-and 3 parts working buffer. The working buffer 
consists of 5 mL stock buffer, 13 mL d-H,O, 7 mL 0.1N 
HCl, 0.25 mL 1M CaCl, (pH 6.1). The stock buffer con- 
sists of 1.94% sodium acetate-3H20, 2.04% sodium 
veronal, and 3.4% NaCl. 
The dehydration stage utilizes solutions of increasing 
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were first washed 3 times for 10 rnin in d-H20. The cubes 
were then washed in the following series of ethanol solu- 
tions: 40% (2 times, 5 rnin each), 60% (3 times, 10 rnin), 
80% (3 times, 10 min), 95% (3 times, 10 rnin), and 100% 
( 3  times, 10 min). 
Infiltration was initiated by washing the cubes in propy- 
lene oxide (3 times, 10 rnin). The cubes were then infil- 
trated for 1.5 h with a 1 : 1 volume ratio of propylene 
oxide and Epon working mixture [4.2 g Epon-812, 2.3 g 
Araldite, 8.35 g dodecenylsuccinic anhydride, 30 drops 
2,4,6-tri(dimethylaminomethyl)phenol]. Final infiltration 
is achieved in a 3:  1 volume ratio of propylene oxide and 
Epon working mixture for 4 h. 
The cubes were then placed in embedding capsules 
filled with the Epon working mixture. The capsules were 
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cured according to the following schedule: 12 h at 35"C, 
12 h at 45"C, and 36 h at 60°C. 
Silver sections (-600 A thick) were cut with an ultrami- 
crotome and picked up onto 300-mesh copper grids. The 
sections were stained for 1 h with saturated uranyl acetate 
and 10 min with lead citrate. The lead citrate stain was 
prepared as follows: add 1.33 g lead nitrate and 1.76 g 
sodium citrate to 30 mL boiled d-H,O, add 8 mL 1N 
NaOH and enough d-H,O to bring the volume to 50 mL, 
and mix until precipitate dissolves. 
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Analysis of Cell Components 
Protein was determined with the Bradford dye binding 
assay using bovine serum albumin as standard.' Interfer- 
ence by Triton XlOO was accounted for by ensuring that 
every assay sample was 0.2% Triton. In order to determine 
the amount of unreleased protein from the sample pellets, 
all samples were treated for 5 min with 1N NaOH at 
100°C. 
DNA was determined by the diphenylamine reaction. lo 
Two 45-min extractions at 70°C with 0.5N HClO, were 
used to release DNA from the sample pellets. Interference 
from guanidine was accounted for by ensuring that every 
assay sample was 0.4M guanidine. 
RNA was determined by the orcinol procedure.'' Two 
15-min extractions at 70°C in 0.5N HC10, were used to re- 
lease RNA from the sample pellets. Interference from Tri- 
ton XlOO was accounted for by making each sample 







Escherichia coli cell counts were determined with a 
Hausser cell counting chamber. The procedure was as fol- 
lows: dilute the original sample in O.1M Tris, pH 9.0, to 
give a cell density of 22 kletts, mix 0.1 mL this diluted 
cell suspension with 0.8 mL 0.1M Tris, add 0.1 mL 
methylene blue staining solution, fill the counting chamber 
by capillary action, let cells settle for 30 min, and count 
cells, being sure to adjust focus to get any unsettled cells 
or cells adhering to the cover slip. The methylene blue 
staining solution consisted of 1 part methylene blue stock 
solution and 9 parts 0.1M Tris. The methylene blue stock 
solution was prepared as follows: dissolve 0.3 g methylene 
blue in 30 mL 95% ethanol, add 100 mL distilled water, 
and gravity filter through Whatman No. 1 filter paper. 
Enzymatic Activity 
The enzymes used in these studies were obtained from 
mechanically disrupted cells. A dense cell suspension 
(30,000 kletts) in 0.1M Tris, pH 7.0, was mechanically 
disrupted for 5 min as described previously. The disrupted 
cell suspension was centrifuged at 13,OOOg for 30 min. 
The resulting supernatant was used as the stock enzyme 
solution. 
The stock enzyme solution was used to prepare the con- 
trol (0.1M Tris) and the gu-HC1-Triton treatments. 
Four treatments were investigated: 0.1M gu-HCl/O.5% 
Triton X100, 0.2M/0.5%, 1M/0.5%, and 2M/0.5%. The 
treatments consisted of adding a portion of the enzyme 
stock solution to a solution containing the appropriate 
guanidine and Triton concentrations. The control was pre- 
pared by adding the same portion of the enzyme stock so- 
lution to the buffer. Both were maintained at 4°C for 
specific periods of time. The treatment and control solu- 
tions were then assayed for the enzymatic activity of 
glucose-6-phosphate,i* fumarase," acid phosphatase,14 
isocitrate dehydrogenase, l3 and alkaline phosphatase. l4 The 
substrate concentration in all studies was sufficiently high 
to saturate the enzyme. Therefore, the rate of enzymatic 
activity was constant and did not initially vary with time as 
the substrate was consumed. 
RESULTS AND DISCUSSION 
Assessment of Protein Release Kinetics 
As described in the Methods section, the permeabiliza- 
tion process was initiated by adding a buffered solution 
containing guanidine-HC1 and Triton XlOO to a buffered 
cell suspension. Figures 1 and 2 show the supernatant, pel- 
let, and whole-broth protein concentrations as a function of 
time for a treatment consisting of 2M guanidine and 2% 
Triton (henceforth, such a treatment will be designated 
20 , 
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Whole-broth and supematant protein concentration profiles Figure I .  
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Pellet protein concentration profiles during treatment with Figure 2. 
2M guanidine-HCI and 2% Triton X100. 
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2 M / 2 % ) .  For this treatment, the supernatant protein 
concentration rose to a final value of 5 g/L within ap- 
proximately 1 h. The protein concentration of the pellet 
decreased from nearly 100 g/L (based on pellet volume) to 
approximately 70 g/L and the whole broth was constant at 
17.3 g/L. It should be noted that cells exposed only to the 
treatment buffer do not experience any protein release. 
The protein data were normalized to a form that is more 
informative and amenable to making comparisons to other 
treatments. The normalization procedure involved dividing 
the supernatant protein concentration by the whole-broth 
protein concentration. In this way, the protein release is 
expressed as a percentage toward complete protein release 
with 100% being the maximum attainable release. With 
this method of presenting the data, it is seen that treatment 
with 2M guanidine and 2% Triton leads to release of 
Î 28% of the cellular protein (Fig. 3 ) .  
Assessment of the Supernatant, pellet, and whole-broth 
protein concentrations provides a means to check the relia- 
bility of the data because a mass balance can be per- 
formed. The sum of the protein contents of the supernatant 
and pellet divided by the total solution volume should 
equal the value obtained from a protein assay on the whole 
solution. As seen in Figure 4, the mass balance closes to 
within = 10%. 
Since the protein release results are in terms of total 
protein, these data provide no information about the origi- 
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Normalized protein release profiles for 2M/2% treatment. Figure 3. 






Z 14 - 
W 
I- g 1 2  - 
a 
13 I ' I . 1 . 1 . I .  
nal location of the protein. The protein found in the super- 
natant at a given time is protein that has been released 
from the cells, but it is not known how much of the protein 
is from the outer membrane, inner membrane, cytoplasm, 
or periplasm. Two-dimensional electrophoresis gels (not 
shown) indicate that the protein released is similar to 
the overall cellular protein pool. Proteins that span the 
entire spectrum of isoelectric points and molecular weights 
are released. This is a clear indication that intracellular 
and membranous proteins are being released by these 
treatments. 
Effect of Varying the Gu-HCI and Triton XlOO 
Concentrations 
A large number of different treatments were studied to 
evaluate the effect of guanidine and Triton XlOO on the 
protein release process. Various combinations of Triton 
concentrations up to 2% and guanidine concentrations up 
to 4.OM were examined. Protein release profiles from 
more than 35 treatments were evaluated. A summary of 
the protein release yields, i.e., the final protein release 
value, is shown in Figure 5 .  Note that the guanidine and 
Triton concentrations are plotted on a logarithm scale. Al- 
though it is impossible to show a zero concentration on a 
logarithm scale, it should be noted that the back and left 
edges of this figure correspond closely to the release ob- 
tained when only guanidine or only Triton were used, re- 
spectively. 
Figure 5 can be viewed as consisting of several regions 
with distinct characteristics. The left edge consists of 
treatments using essentially only Triton. Triton XlOO at 
concentrations up to 2% is incapable of causing any appre- 
ciable protein release. The back edge corresponds to treat- 
ments using essentially only guanidine. At guanidine 
concentrations greater than = 1 .OM, substantial protein re- 
lease is observed even in the absence of Triton. Protein 
release time profiles for treatments using different concen- 
trations of guanidine in the absence of Triton are shown in 
Figure 6. At concentrations below 0.25M, no observable 
protein release occurs. There appears to be a critical 
gu-HC1 concentration above which substantial protein 
release is observed. A gradual protein release up to 20% 
is observed with 2M guanidine and a very rapid release is 
observed with 4M. 
The right edge of Figure 5 represents another region 
with distinct properties. In this region, where the 
guanidine concentration is greater than 2 M ,  significant 
protein release is observed. The guanidine concentration is 
sufficiently high to induce protein release, and addition of 
Triton does not substantially affect the final yield. How- 
ever, these data do not give an indication of the rate at 
which protein is released. Figure 7 shows the protein re- 
lease time profiles for 2 M ,  2%, and 2 M / 2 %  treatments. 
Although the final yield of the 2 M / 2 %  treatment is higher 
than the 2M treatment, the more pronounced effect of 
adding Triton is an enhancement of the release rate. Al- 
though Triton itself is not capable of releasing more than 
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Figure 6. Protein release profiles for treatments using different concen- 
trations of guanidine-HC1 in absence of Triton X100. Squares, open dia- 
monds, and triangles correspond to the 0 .05M,  0.12M. and 0.25M 
guanidine treatments, respectively. 
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Figure 7.  
2% Triton. 
Synergistic effect between 2M guanidine-HCl and 
= 10% of the cell protein, it interacts with cells exposed to 
2M guanidine in a manner which significantly increases 
the protein release rate. 
The most dramatic effects on the protein release yield 
and rate are observed in the central region of Figure 5. A 
very pronounced synergistic effect between guanidine and 
Triton occurs for treatments in this region. As an example, 
the protein release time profiles of the peak treatment of 
the front face of Figure 5 ,  which corresponds to = 0.12M 
guanidine and 2% Triton, is shown in Figure 8 .  Also 
shown in Figure 8 are the profiles obtained when 0.12M 
guanidine and 2% Triton are used individually. Treatment 
with either 0.12M guanidine or 2% Triton releases very 
little protein, yet -50% of the cell protein is released upon 
exposure to both chemicals. 
The central region of Figure 5 will be discussed in 
greater detail by examining two sets of treatments. One set 
40 5 - 
I 0 ‘iV 1 
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TIME ( h o u r s )  
Synergistic effect between 0.12M guanidine-HC1 and Figure 8. 
2% Triton. 
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TIME (hours) 
Protein release profiles for treatments using Triton concentra- Figure 9. 
tions between 0 and 2% and guanidine concentration of 0.1UI. 
consists of using 0.12M guanidine and various Triton con- 
centrations. These treatments define the central ridge of 
Figure 4. The second set of treatments, which consists of 
0.5% Triton and various guanidine concentrations, defines 
the wave-like behavior of the front face of Figure 5 .  
The protein release time profiles for treatments consist- 
ing of 0.12M guanidine and Triton concentrations between 
0 and 2% are shown in Figure 9. At concentration of 
0.12M guanidine alone resulted in an imperceptible level 
of protein release. Addition of a small amount of Triton, 
namely 0.02%, resulted in a slow release of protein that at- 
tained a value of 12% within 36 h. A dramatic increase in 
the protein release is observed when the Triton concentra- 
tion is increased to 0.1%. Subsequent increases to 0.5 
and 2% result in marginally different protein release pro- 
files. These data define the central ridge of Figure 5 as ris- 
ing rapidly between 0 and 0.1% Triton to a plateau value 
which remains constant as the Triton concentration is in- 
creased to 2%. 
The most startling feature of Figure 5 is the wave-like 
dependence of the protein release yield on guanidine. 
Figure 10 shows the protein release yields obtained for 
treatments consisting of 0.5% Triton and guanidine con- 
centrations from 0.01M to 3.5M. As the guanidine concen- 
tration is increased from 0.01M to 0. lM, a steady increase 
in the protein release yield is observed. A maximum value 
60 1 1 
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Figure 10. 
lease yield of treatments using 0.5% Triton X100. 
Semilog plot of influence of guanidine-HC1 on protein re- 
of --- 50% is observed for concentrations near O.1M- 
0.12M. As the guanidine concentration is increased fur- 
ther, the yield drastically declines to a minimum near l .OM 
before rising again when very high guanidine concentra- 
tions such as 3.5M are used. 
Although the protein release yield exhibits a complex 
dependence on the guanidine concentration, the protein re- 
lease rate increases monotonically with increasing 
guanidine. Figure 11 shows the initial protein release rates 
normalized to the initial release rate of the 3.5M/0.5% 
treatment. From these data, the initial rate of protein re- 
lease is observed to increase with increasing guanidine. 
The nature of the complex yield dependence and monotoni- 
cally increasing rate dependence will be discussed in a fu- 
ture paper. 
Comparison between Mechanical Disruption and 
Chemical Permeabilization 
As described previously, two of the problems inherent to 
mechanical disruption are the release of nucleic acids and 
extensive cell fragmentation. A characterization of protein 
release by mechanical disruption is shown in Figure 12. 
The percentage of release of protein, DNA, and RNA are 
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Figure 11. Initial protein release rates of treatments using guanidine- 
HCl concentrations between 0.01M and 3.5M and Triton concentration of 
0.5%. Rates normalized to 3.5M/0.5% treatment. 
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Characterization of protein release by mechanical disrup- Figure 12. 
tion. 
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normalized cell concentration as determined with a bacte- 
rial counting chamber. The decrease in cell concentration 
with increasing disruption time indicates that extensive 
fragmentation of the cells is occurring during the process. 
A nearly mirror image release of protein, DNA, and RNA 
results as cellular components spill out into the extracel- 
lular fluid. The maximum protein release, -- 70%, is in- 
dicative of a significant amount of cellular protein being 
associated with the membrane and wall fragments. 
A similar comparison for cells treated with 2 M  
guanidine and 2% Triton is shown in Figure 13. For this 
study, the protein release leveled off at = 35%. RNA is 
released to a lesser extent (= 15%), and very little DNA 
(= 5%) is released from the cells. Furthermore, the cell 
concentration remains constant during the treatment. 
From these data, two major differences between chemi- 
cal permeabilization and mechanical disruption can be 
identified. First, there is a selective release of protein over 
nucleic acid. The retention of DNA inside the cell may be 
a result of DNA’s high molecular weight. This may benefit 
the purification process by eliminating or simplifying the 
nucleic acid removal step. 
The second major difference between chemical perme- 
abilization and mechanical disruption is that the release oc- 
curs by fundamentally different mechanisms. With 
mechanical disruption the cells are essentially tom apart, 
whereas with chemical permeabilization the cell structure 
as observed with a light microscope is still present. 
Clearly, the chemical treatment has altered the cell 
structure in some manner to enable intracehlar compo- 
nents to be released. An indication of the extent of cell 
structure alteration during the chemical treatment can be 
Figure 14. Electron micrograph of E .  coii cell prior to chemical treat- 
ment (107,@30X). 
obtained by examining the cells with transmission electron 
microscopy. Figure 14 is an electron micrograph of a cell 
prior to chemical treatment. The cell structure can be re- 
solved into five distinct layers. The outer wall is a triple 
layered structure, of which the outer two layers correspond 
to the outer membrane. The third line corresponds to the 
peptidoglycan layer. Just interior to the outer wall is the 
periplasmic space. The inner membrane is also resolved 
into two lines representing the two leaflets of the bilayer. 
The inner membrane is best resolved along the right edge 
of the cell in Figure 14. 
Figure 15 is an electron micrograph of cells exposed for 
4 h to 2M guanidine and 2% Triton. The inner membrane 
has been completely solubilized during the treatment. The 
triple-layered structure that remains corresponds to the 
outer wall. Since an intact outer wall is only permeable to 
small compounds, guanidine and Triton must obviously 
have affected the outer wall to some extent in order to al- 
low release of proteins. However, this interaction appears 
to be at the molecular level rather than at the macroscopic 
level as evidenced by the absence of any large gaps or 
tears in the outer wall. Furthermore, there are no instances 
where a large portion of either the outer membrane or the 
peptidoglycan layer has been removed. The outer wall is 
either clearly resolved into three lines or the wall appears 
blurred, which can result from imperfect sectioning of the 
cells. The interaction at the molecular level may involve 
solubilization of a portion of the outer-wall lipids and/or 
proteins. 
Comparison of Figures 14 and 15 also indicates substan- 
tial alteration of the intracellular material. In the untreated 
cell, the intracellular material has a homogeneous granular 
appearance. The 2M/2% treatment has led to the forma- 
0 2 4 6 8 tion of distinct dense regions. The nature of these intracel- 
lular alterations and its role in determining the protein 
release rate and yield will be discussed in a later paper. 
TIME (hours) 
Figure 13. Characterization of protein release by W / 2 %  treatment. 
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Figure 15. 
HCl and 2% Triton (142,OOOX). 
Electron micrograph of cells treated with 2M guanidine- 
Effect of Repeated Treatments 
One major limitation for some of the treatments is the 
incomplete extent to which the cell protein is released. 
From a processing standpoint, it is imperative that the 
yield be maximized. One possible approach to improving 
the yield would be to expose the cells to a second treat- 
ment. The results of using two successive exposures to a 
number of treatments is shown in Figure 16. The arrow in- 
dicates the time at which a portion of the cells were cen- 
trifuged and resuspended i n  a solution containing 
guanidine and Triton at the same concentrations as the first 
treatment. The dashed line represents the cumulative 
protein release resulting when a portion of the cells is re- 
suspended in buffer and the solid line is the cumulative re- 
lease of the two exposures to guanidine and Triton. For 
these treatments as well as others not shown, no significant 
protein release was observed during the second treatment. 
At this point, very little investigation has been done of 
other means of increasing the yield. For example, it may 
be advantageous to expose the cells to two different treat- 
ments. Alternatively, yield improvements may be observed 
if other cell disruption techniques are utilized in concert 
with exposure to guanidine and Triton. A few possibilities 
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Protein release profiles of cells exposed to two successive Figure 16. 
treatments. 
is believed to bind to membrane-stabilizing cations, or uti- 
lizing other permeabilizing chemicals. 
Effect of Guanidine and Triton XlOO on Product 
Activity 
Another important processing consideration is the effect 
of the chemical permeabilizing process on product activity. 
Although the influence of exposure to guanidine and Triton 
is obviously product dependent, a general indication of the 
effect of the chemical treatment was obtained by evaluat- 
ing how the activities of five E .  coli enzymes were altered 
by exposure to varying levels of guanidine and Triton. Fig- 
ure 17 shows the effect of exposing five enzymes to 
four treatments: 0 . 1 M / . 5 % ,  0 . 2 M / . 5 % ,  1 M / . 5 % ,  and 
2h4/.5%. The activities were assessed after 24 h exposure 
to 0.1M/.5% and 0.2M/ .5% and after 6 h exposure to 
1M/.5% and 2M/.5%. These times correspond to the ap- 
proximate treatment times needed to achieve the maximum 
protein release yield. Also shown for reference are the 
protein release yields observed for these treatments. The 
enzyme activities are displayed relative to the activity 
observed in a buffered solution which did not contain 
guanidine or Triton. From this data, it is clear that the 
O.lM/.S% and 0.2M/.5% treatments can be considered to 
be mild, although some adverse affect on two of the en- 
zymes was detected. These treatments would probably not 
cause adverse effects on the product. In contrast, treatment 
with high concentrations of guanidine such as IM or 2M 
significantly decreases the activity of these enzymes. 
Guanidine's adverse effect is probably related to its well- 
known ability to denature proteins. l5-I8 
The full implications of the data of Figure 17 depends 
on whether the adverse effects are irreversible. It is quite 
apparent that proteins will be adversely affected by treat- 
ments which utilize high guanidine concentrations. 
However, in a number of cases, protein denaturation is re- 
versible and enzyme activity can be recovered upon re- 
moval of the d e n a t ~ r a n t . ' ~ - ~ '  This is also possible for 
nonenzyme protein products. However, if a particular 
protein product's activity cannot be recovered, a milder 
treatment such as 0.1M/.5% may be appropriate. 
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Figure 17. Effect of various treatments on activity of five E .  coli enzymes. ND 
indicates this study was not done and ppf indicates precipitate formed upon adding 
assay reagents and guanidine-Triton solution. 
CONCLUSIONS 
Guanidine-HC1 and Triton XlOO have been shown to be 
capable of permeabilizing E .  coli to protein. Variation of 
the guanidine and Triton concentrations was found to lead 
to a spectrum of protein release processes with widely dif- 
ferent kinetic properties. These kinetic properties have 
been mapped out for guanidine concentrations up to 4M 
and Triton concentrations up to 2%.  Transmission electron 
microscopy revealed that the permeabilization mechanism 
involves a solubilization of the inner membrane. The 
outer-wall alteration apparently occurs at the molecular 
level because extensive disruption of the outer membrane 
or peptidoglycan layer was not observed. Essentially, treat- 
ment with guanidine and Triton resulted in unfragmented 
cells whose structures are characterized by an outer wall 
which acts as the final barrier to transport. 
Two different regions in the concentration space which 
give substantial protein release have been identified. In 
one region, characterized by high guanidine concentra- 
tions, the process is dominated by the action of guanidine. 
Guanidine alone at concentrations greater than 2M is ca- 
pable of altering the cell structure sufficiently to induce 
substantial protein release. In this region, Triton's primary 
effect is an enhancement of the protein release rate, pos- 
sibly due to its effectiveness in  solubilizing the inner 
membrane. A second region which results in significant 
amounts of protein release consists of guanidine concentra- 
tions near 0.1M and Triton concentrations between 0.5 and 
2%. Although high protein release yields are observed in 
this region, the protein release rate is low. Approximately 
15 h is required to achieve high protein release yields in 
this region as opposed to approximately 1 h in the region 
characterized by guanidine concentrations greater than 2M. 
These two regions also differ in that a substantial synergis- 
tic effect between Triton and guanidine is observed in the 
second region. Although 0.1M guanidine and 0.5% Triton 
are individually incapable of inducing an appreciable 
amount of protein release, when used together, protein re- 
lease yields near 50% are obtained. 
Chemical treatment with guanidine and Triton was 
shown to have certain advantages and disadvantages with 
respect to mechanical disruption. One advantage is avoid- 
ance of cell fragmentation. The E .  coli cells still retain 
their gross morphological characteristics after treatment, 
and consequently the solution can be readily clarified. An- 
other advantage which was demonstrated for treatments 
with high gu-HC1 concentrations is retention of the nucleic 
acids inside the cell structure. This can help the purifica- 
tion process by eliminating or simplifying the nucleic acid 
removal step. There are also the obvious advantages of re- 
placing mechanical disruption devices with a simple batch 
operation which employs only a stirred vessel. Some dis- 
advantages include the necessity to remove the chemicals 
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from the final product, any irreversible loss of product ac- 
tivity caused by the chemicals, and suboptimum yields. 
Furthermore, the treatment wouId not be applicable for re- 
combinant products which form inclusion bodies unless the 
guanidine concentration is high enough to solubilize 
the product. The net balance between the advantages 
and disadvantages would depend on the protein product 
of interest. 
Probably the most striking result of this research was the 
complex dependence of the release yield on the guanidine 
concentration for treatments that used Triton concentra- 
tions between 0.5 and 2%. At very low guanidine concen- 
trations, such as 0.01M, the release is negligible. As the 
gu-HC1 concentration is increased to -0.05M, a substan- 
tial amount of cell protein is released. At O.1M gu-HC1, 
the release yield approaches 50-60%. Beyond 0.12M gu- 
HCl, the yield drastically declines until a minimum is ob- 
tained near 1M gu-HCI. As the gu-HC1 concentration is 
increased even further, the yield begins to increase again. 
Although the protein release yield varies in this complex 
wave-like manner, the protein release rate varies monotoni- 
cally with increasing gu-HC1. The phenomena which lead 
to these results have been investigated by Hettwer2’ and 
will be described in a forthcoming paper. 
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